Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

AIMS: In the era of personalized medicine, it is of utmost importance to be able to identify subjects at the highest cardiovascular (CV) risk. To date, single biomarkers have failed to markedly improve the estimation of CV risk. Using novel technology, simultaneous assessment of large numbers of bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogeveen, Renate M, Pereira, João P Belo, Nurmohamed, Nick S, Zampoleri, Veronica, Bom, Michiel J, Baragetti, Andrea, Boekholdt, S Matthijs, Knaapen, Paul, Khaw, Kay-Tee, Wareham, Nicholas J, Groen, Albert K, Catapano, Alberico L, Koenig, Wolfgang, Levin, Evgeni, Stroes, Erik S G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672529/
https://www.ncbi.nlm.nih.gov/pubmed/32808014
http://dx.doi.org/10.1093/eurheartj/ehaa648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672529/
https://www.ncbi.nlm.nih.gov/pubmed/32808014
http://dx.doi.org/10.1093/eurheartj/ehaa648

Ejemplares similares